Journal of Drug Targeting

Papers
(The median citation count of Journal of Drug Targeting is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
A comprehensive review on the antiviral activities of chalcones62
CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia56
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances51
Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects50
A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances34
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease32
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-1931
Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation31
Stability issues and approaches to stabilised nanoparticles based drug delivery system29
Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications28
Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications28
The relevant targets of anti-oxidative stress: a review28
3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status28
Manganese dioxide (MnO2) based nanomaterials for cancer therapies and theranostics27
Targetting ferroptosis for blood cell-related diseases27
ABC transporters in breast cancer: their roles in multidrug resistance and beyond26
Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety26
Fabrication and characterisation of self-applicating heparin sodium microneedle patches26
Current status of micro/nanomotors in drug delivery25
Potential inhibitors of SARS-CoV-2: recent advances24
Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumours24
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide24
Active-site molecular docking of nigellidine with nucleocapsid–NSP2–MPro of COVID-19 and to human IL1R–IL6R and strong antioxidant role of Nigella sativa in experimental rats23
Mitochondria autophagy: a potential target for cancer therapy22
Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis22
Niosomal formulation for antibacterial applications21
Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation21
An updated review on exosomes: biosynthesis to clinical applications20
Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery20
Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells19
Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway19
A γ-cyclodextrin-based metal–organic framework (γ-CD-MOF): a review of recent advances for drug delivery application19
New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies19
Mitochondrial delivery of microRNA mimic let-7b to NSCLC cells by PAMAM-based nanoparticles18
Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway18
Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications18
MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson’s disease17
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities16
Nanoliposomes as drug delivery systems: safety concerns16
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer’s disease16
Methods for fabricating oxygen releasing biomaterials16
Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer15
Immunotoxins and nanobody-based immunotoxins: review and update15
PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery15
Micro and nanorobot-based drug delivery: an overview15
The role of peptide-based therapeutics in oncotherapy15
Progress in tumour-targeted drug delivery based on cell-penetrating peptides15
A novel progress of drug delivery system for organelle targeting in tumour cells15
The mechanisms of lncRNA GAS5 in cardiovascular cells and its potential as novel therapeutic target15
Targeting PRAS40: a novel therapeutic strategy for human diseases15
Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer15
Mesencephalic astrocyte-derived neurotrophic factor restores blood–brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway15
EGFR and anti-EGFR nanobodies: review and update15
Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver14
Influences of different sugar ligands on targeted delivery of liposomes14
Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer’s disease in rats via the Rho/ROCK signalling pathway14
Iron metabolism in Pseudomonas aeruginosa biofilm and the involved iron-targeted anti-biofilm strategies14
Biomedical application of chondroitin sulfate with nanoparticles in drug delivery systems: systematic review14
Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide13
MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression13
Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac)13
New generation of viral nanoparticles for targeted drug delivery in cancer therapy13
Effect of polymer microneedle pre-treatment on drug distributions in the skin in vivo13
Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism13
A mechanistic perspective on targeting bacterial drug resistance with nanoparticles13
TIGIT/PVR and LncRNA ANRIL dual-targetable PAMAM polymeric nanoparticles efficiently inhibited the hepatoma carcinoma by combination of immunotherapy and gene therapy13
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease12
Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects12
Significant metabolic alterations in patients with hepatitis B virus replication observed via serum untargeted metabolomics shed new light on hepatitis B virus infection12
Effects and mechanisms of natural plant active compounds for the treatment of osteoclast-mediated bone destructive diseases12
Mycobacterial ethambutol responsive genes and implications in antibiotics resistance12
Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo12
Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art12
Functionality of receptor targeted zinc-insulin quantum clusters in skin tissue augmentation and bioimaging12
Exosome vesicle as a nano-therapeutic carrier for breast cancer12
Envelope proteins as antiviral drug target12
HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment11
Enzyme-instructed self-assembly of the stereoisomers of pentapeptides to form biocompatible supramolecular hydrogels11
Hyaluronic acid-coated metal-organic frameworks benefit the ROS-mediated apoptosis and amplified anticancer activity of artesunate11
Mitochondrial dysfunction and mitochondrion-targeted therapeutics in liver diseases11
Sirtuins as therapeutic targets for improving delayed wound healing in diabetes11
Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles11
Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer11
Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment10
Tumour microenvironment-responsive nanoplatform based on biodegradable liposome-coated hollow MnO2 for synergistically enhanced chemotherapy and photodynamic therapy10
Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists10
Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer10
Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis10
Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth10
Light mediated drug delivery systems: a review10
Four generations of EGFR TKIs associated with different pathogenic mutations in non-small cell lung carcinoma9
Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes9
Improving protection effects of eucalyptol via carboxymethyl chitosan-coated lipid nanoparticles on hyperglycaemia-induced vascular endothelial injury in rats9
Biomimetic Ca2+ nanogenerator based on ions interference strategy for tumour-specific therapy9
Lectin recognition and hepatocyte endocytosis of GalNAc-decorated nanostructured lipid carriers9
Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme9
Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review9
Coadministration of liposomal methylglyoxal increases the activity of amphotericin B againstCandida albicansin leukopoenic mice9
ZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, targeted delivery of dexamethasone to arthritic joints9
Ultrasound image-guided gene delivery using three-dimensional diagnostic ultrasound and lipid-based microbubbles9
PVAT targets VSMCs to regulate vascular remodelling: angel or demon9
A pH-Driven indomethacin-loaded nanomedicine for effective rheumatoid arthritis therapy by combining with photothermal therapy9
Effect of Malt-PEG-Abz@RSL3 micelles on HepG2 cells based on NADPH depletion and GPX4 inhibition in ferroptosis9
Machine learning-guided evolution of BMP-2 knuckle Epitope-Derived osteogenic peptides to target BMP receptor II9
Metformin combats obesity by targeting FTO in an m6A-YTHDF2-dependent manner9
How to use macrophages to realise the treatment of tumour8
Drug repurposing strategies and key challenges for COVID-19 management8
Non-coding RNAs enhance the apoptosis efficacy of therapeutic agents used for the treatment of glioblastoma multiform8
Application of nanotechnology in management and treatment of diabetic wounds8
Engineering mesenchymal stem cells: a novel therapeutic approach in breast cancer8
Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials8
Molecular and cellular biology of PCSK9: impact on glucose homeostasis8
New designed pH-responsive histidine-rich peptides with antitumor activity8
Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages8
Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment8
Development of stimuli-responsive intelligent polymer micelles for the delivery of doxorubicin8
Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review8
Therapeutic advances in cardiac targeted drug delivery: from theory to practice8
Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons8
Diethyldithiocarbamate encapsulation reduces toxicity and promotes leishmanicidal effect through apoptosis-like mechanism in promastigote and ROS production by macrophage7
Metformin protects cardiomyocytes against oxygen-glucose deprivation injury by promoting autophagic flux through AMPK pathway7
Injectablein-situgel depot system for targeted delivery of biologics to the retina7
Tumour targeted polymer nanoparticles co-loaded with docetaxel and siCCAT2 for combination therapy of lung cancer7
Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells7
Lymphatic targeting for therapeutic application using nanoparticulate systems7
The ameliorating approach of nanorobotics in the novel drug delivery systems: a mechanistic review7
The role of miRNAs and lncRNAs in conferring resistance to doxorubicin7
Olaparib@human serum albumin nanoparticles as sustained drug-releasing tumour-targeting nanomedicine to inhibit growth and metastasis in the mouse model of triple-negative breast cancer7
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance7
Discovery of necrosis avidity of rhein and its applications in necrosis imaging6
Therapeutic drugs and drug delivery systems targeting stromal cells for cancer therapy: a review6
Location of stimuli-responsive peptide sequences within silk-elastinlike protein-based polymers affects nanostructure assembly and drug–polymer interactions6
Current approaches and future prospects of nanofibers: a special focus on antimicrobial drug delivery6
Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery6
Macrophage targeted triptolide micelles capable of cGAS-STING pathway inhibition for rheumatoid arthritis treatment6
Nanosystem functionalization strategies for prostate cancer treatment: a review6
Advances in autophagy as a target in the treatment of tumours6
Fabrication techniques for the preparation of orally administered insulin nanoparticles6
Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancer6
Vascular priming with RRx-001 to increase the uptake and accumulation of temozolomide and irinotecan in orthotopically implanted gliomas6
miR-1/133a and miR-206/133b clusters overcome HGF induced gefitinib resistance in non-small cell lung cancers with EGFR sensitive mutations6
Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer6
Smart delivery of epirubicin to cancer cells using aptamer-modified ferritin nanoparticles6
Detecting and targeting neurodegenerative disorders using electrospun nanofibrous matrices: current status and applications6
Virulence-attenuated Salmonella engineered to secrete immunomodulators reduce tumour growth and increase survival in an autochthonous mouse model of breast cancer5
T807-modified human serum albumin biomimetic nanoparticles for targeted drug delivery across the blood–brain barrier5
Exploiting drug delivery systems for oral route in the peptic ulcer disease treatment5
Tumour targetable and microenvironment-responsive nanoparticles simultaneously disrupt the PD-1/PD-L1 pathway and MAPK/ERK/JNK pathway for efficient treatment of colorectal cancer5
Neglected tropical diseases and infectious illnesses: potential targeted peptides employed as hits compounds in drug design5
Salmonella entericaTyphimurium engineered for nontoxic systemic colonization of autochthonous tumors5
Graphene quantum dots (GQDs) nanoarchitectonics for theranostic application in lung cancer5
Novel anti-PD-L1 peptide selected from combinatorial phage library inhibits tumor cell growth and restores T-cell activity5
Recent advancement on albumin nanoparticles in treating lung carcinoma5
Dual-targeted colon-based integrated micelle drug delivery system for treatment of ulcerative colitis5
Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment5
Poly-γ-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy5
Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells5
Biomimetic graphene oxide quantum dots nanoparticles targeted photothermal-chemotherapy for gastric cancer5
Recent advances in nanoscale targeted therapy of HER2-positive breast cancer5
A bispecific decoy receptor VEGFR-EGFR/Fc binding EGF-like ligands and VEGF shows potent antitumor efficacy5
A topical formulation containing quercetin-loaded microcapsules protects against oxidative and inflammatory skin alterations triggered by UVB irradiation: enhancement of activity by microencapsulation5
Demonstration of ultrasound-mediated therapeutic delivery of fibrin-targeted pioglitazone-loaded echogenic liposomes into the arterial bed for attenuation of peri-stent restenosis4
Therapeutic effects of the gold nanoparticle on obesity-triggered neuroinflammation: a review4
Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer4
Mucus- and pH-mediated controlled release of core-shell chitosan nanoparticles in the gastrointestinal tract for diabetes treatment4
Alkoxy cyanoacrylate-based nanoparticles with stealth and brain-targeting properties4
Effect of PEG anchor in PEGylation of folate-modified cationic liposomes with PEG-derivatives on systemic siRNA delivery into the Tumor4
Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer4
Epigenetic modulation: Research progress on histone acetylation levels in major depressive disorders4
Study on lipid nanomicelles targeting placenta for the treatment of preeclampsia4
Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review4
Protective effects of BP-1-102 against intracranial aneurysms-induced impairments in mice4
Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy4
Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, a4
Combination immunotherapy of oncolytic virus nanovesicles and PD-1 blockade effectively enhances therapeutic effects and boosts antitumour immune response4
0.026526927947998